Company Presentation • 30 Jul 2026 18:00
Q1 2027
Company Presentation • 13 May 2026 18:00
Q4 2026
Company Presentation • 29 Mar 2026 08:30
Study Update
Company Presentation • 29 Jan 2026 18:30
Q3 2026
Company Presentation • 13 Jan 2026 09:15
𝛼SK or SearchENTITY
Takeda Pharmaceutical (TAK US)
Takeda Pharmaceutical (TAK US)
14
Analysis
Health Care • Japan
Takeda Pharmaceutical Company Limited is engaged in research and development, manufacturing, sales and marketing, and import and export of pharmaceutical drugs. The Company focuses on the core therapeutic areas of oncology, gastrointestinal, and central nervous system disease.
morex